Term ends Nov 11, 2030 · High confidence
20-year base term ends Nov 11, 2030
Filed Apr 20, 2016 as application 15/133,783 · Granted Apr 3, 2018
Base term plus 11 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2010
2030
Clock starts
Nov 11, 2010
Nov 11, 2010
Term ends
Nov 11, 2030
Nov 11, 2030
Granted
Apr 3, 2018
Apr 3, 2018
base term
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
11
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,233,253, US 9,321,842, US 9,487,584.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 11 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 11, 2010, when application PCT/EP2010/006888, the earliest non-provisional in its chain, was filed (this one was filed Apr 20, 2016) | Nov 11, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +11 days, USPTO patent term adjustment record | Nov 22, 2030 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,233,253, US 9,321,842, US 9,487,584) | capped to Nov 11, 2030 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 11, 2030 | High confidence |
Partial family
| Application PCT/EP2010/006888 | PCT application no patent term | no patent term |
| US 9,487,584 | In force Nov 2030 | Nov 2030 |
| US 9,932,401 | this patent Nov 2030 | Nov 2030 |
| US 10,745,477 | In force Nov 2030 | Nov 2030 |
| US 11,858,988 | In force Nov 2030 | Nov 2030 |
| Application 18/520,242 | Pending not computed | not computed |
Partial: 1 of the 6 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 10, 2016 Reel 38877, frame 672 | Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, Michael | Ganymed Pharmaceuticals AG; Johannes Gutenberg-Universitat Mainz | Assignment of Assignor's Interest |
| Jun 10, 2016 reel/frame not recorded | Tureci, Ozlem; Woll, Stefan; Sahin, Ugur; Kreuzberg, Maria; Walter, Korden; Hubner, Bernd; Koslowski, Michael; Erdeljan, Michael | Ganymed Pharmaceuticals AG | Assignment of Assignor's Interest |
| Jun 10, 2016 reel/frame not recorded | Tureci, Ozlem; Woll, Stefan; Sahin, Ugur; Kreuzberg, Maria; Walter, Korden; Hubner, Bernd; Koslowski, Michael; Erdeljan, Michael | Johannes Gutenberg-Universitat Mainz | Assignment of Assignor's Interest |
| Jul 27, 2016 Reel 39492, frame 700 | Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, Michael | Ganymed Pharmaceuticals AG; Johannes Gutenberg-Universitat Mainz | Corrective Assignment to Correct the First Assignee Name Previously Recorded at Reel: 038877 Frame: 0672. Assignor(S) Hereby Confirms the Assignment . |
| Jul 27, 2016 reel/frame not recorded | Tureci, Ozlem; Woll, Stefan; Sahin, Ugur; Kreuzberg, Maria; Walter, Korden; Hubner, Bernd; Koslowski, Michael; Erdeljan, Michael | Ganymed Pharmaceuticals AG | Corrective Assignment to Correct the First Assignee Name Previously Recorded at Reel: 038877 Frame: 0672. Assignor(S) Hereby Confirms the Assignment . |
| Jul 27, 2016 reel/frame not recorded | Tureci, Ozlem; Woll, Stefan; Sahin, Ugur; Kreuzberg, Maria; Walter, Korden; Hubner, Bernd; Koslowski, Michael; Erdeljan, Michael | Johannes Gutenberg-Universitat Mainz | Corrective Assignment to Correct the First Assignee Name Previously Recorded at Reel: 038877 Frame: 0672. Assignor(S) Hereby Confirms the Assignment . |
| Jul 15, 2019 Reel 49749, frame 977 | Ganymed Pharmaceuticals AG | Ganymed Pharmaceuticals GmbH | Assignment of Assignor's Interest |
| Jan 19, 2024 Reel 66174, frame 979 | Ganymed Pharmaceuticals GmbH | Astellas Pharma Inc. | Assignment of Assignor's Interest |
| Jan 19, 2024 Reel 66174, frame 992 | Johannes Gutenberg-Universitat Mainz | Tron - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbH | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Nov 2030
Term ends Nov 11, 2030. Maintenance fees still fall due before then
Note
The 11 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,233,253, US 9,321,842, US 9,487,584.
Citations
10
later US patents cite this one
That is above the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.